By Counterforce Health Team in Tepezza (teprotumumab) —

Blue Cross Blue Shield Florida's Coverage Criteria for Tepezza: What Counts as "Medically Necessary"?

Answer Box: Getting Tepezza Covered by Florida Blue BCBS

Florida Blue requires prior authorization for Tepezza (teprotumumab) with specific thyroid eye disease criteria: active TED diagnosis, Clinical Activity Score documentation, euthyroid status, and ophthalmologist prescriber. Submit PA via Availity.com or call 1-877-719-2583. Coverage decisions are delegated to Prime Therapeutics. First step today: Gather CAS score ≥4, recent thyroid labs (TSH/T3/T4 within 90 days), and proptosis measurements before requesting authorization.

Table of Contents

  1. Policy Overview: How Florida Blue Covers Tepezza
  2. Indication Requirements: Active Thyroid Eye Disease
  3. Step Therapy & Medical Exceptions
  4. Quantity and Frequency Limits
  5. Required Diagnostics and Documentation
  6. Site of Care and Specialty Pharmacy Rules
  7. Evidence to Support Medical Necessity
  8. Sample "Meets Criteria" Documentation
  9. Edge Cases and Special Situations
  10. Appeals Process in Florida
  11. Quick Reference: Coverage Criteria
  12. FAQ

Policy Overview: How Florida Blue Covers Tepezza

Florida Blue (Blue Cross Blue Shield of Florida) delegates Tepezza coverage decisions to Prime Therapeutics, their pharmacy benefits manager. This means your approval comes through Prime's clinical team, not directly from Florida Blue.

Plan Types and Coverage

  • Commercial plans: Prior authorization required for all Tepezza infusions
  • Medicare Advantage: Follow Medicare Part B guidelines with additional plan requirements
  • Medicaid: Coverage varies; check Florida Medicaid formulary
Key Point: Tepezza is covered under your medical benefit (not pharmacy), billed with J-code J3241 at infusion centers.

Where to Find Official Policies:

Indication Requirements: Active Thyroid Eye Disease

FDA-Approved Use

Tepezza is approved for thyroid eye disease (TED), regardless of activity or duration. However, Florida Blue's criteria are more restrictive than the FDA label.

Florida Blue's Medical Necessity Criteria

Based on delegated policies and similar BCBS plans, expect these requirements:

Requirement Details Documentation Needed
Diagnosis Active Thyroid Eye Disease ICD-10: H05.20 (bilateral) or H05.21/H05.22 (unilateral)
Age 18 years or older Date of birth verification
Disease Activity Clinical Activity Score (CAS) ≥4 in at least one eye Complete CAS assessment form
Thyroid Status Euthyroid or mildly abnormal TSH, T3, T4 labs within 90 days
Prescriber Ophthalmologist or endocrinologist Provider credentials verification
Note: While the FDA doesn't require "active" disease, most insurers including Florida Blue still use older criteria requiring inflammation signs.

Step Therapy & Medical Exceptions

Required Prior Treatments

Florida Blue typically requires evidence of:

  1. Corticosteroid trial (oral or IV methylprednisolone)
  2. Documentation of failure, intolerance, or contraindication

Medical Exception Pathways

You can bypass step therapy if you document:

  • Contraindications: Diabetes (relative), active infection, psychiatric history
  • Prior failures: Inadequate response or intolerable side effects
  • Urgent clinical need: Compressive optic neuropathy, severe diplopia

How to Document Exceptions:

  • Include specific adverse reactions with dates
  • Note contraindications with clinical rationale
  • Reference guidelines supporting direct Tepezza use

Quantity and Frequency Limits

Standard Treatment Course

  • Initial dose: 10 mg/kg (typically 3-4 vials for average adult)
  • Subsequent doses: 20 mg/kg every 3 weeks × 7 doses
  • Total course: 8 infusions over approximately 6 months

Authorization Limits

  • Initial approval: 6 months (covers full 8-infusion course)
  • Lifetime maximum: Varies by plan; some limit to one course
  • Retreatment: May require new PA with documented disease progression
Billing Tip: Use J3241 code with correct units (1 unit = 10 mg). A 500 mg vial = 50 units.

Required Diagnostics and Documentation

Clinical Activity Score (CAS) Assessment

Must document CAS ≥4 using the 7-point scale:

  1. Spontaneous retrobulbar pain (past 4 weeks)
  2. Pain on eye movement
  3. Eyelid redness
  4. Eyelid swelling
  5. Conjunctival redness
  6. Chemosis (conjunctival swelling)
  7. Caruncle swelling

Additional Required Measurements

  • Proptosis: Hertel exophthalmometer readings in millimeters
  • Visual fields: If optic nerve involvement suspected
  • Extraocular muscle function: Diplopia assessment
  • Photography: Before/after documentation

Laboratory Requirements

Submit labs within 90 days of PA request:

  • TSH, Free T4, Free T3
  • Consider glucose monitoring plan (diabetes risk)
  • Pregnancy test if applicable

Download the official TED Clinical Documentation Form for standardized assessment.

Site of Care and Specialty Pharmacy Rules

Preferred Infusion Settings

Florida Blue prefers lower-cost settings over hospital outpatient departments:

  1. Physician office infusion centers (preferred)
  2. Freestanding infusion centers
  3. Hospital outpatient (may require additional justification)

First Infusion vs. Subsequent Doses

  • First infusion: Generally covered in office settings
  • Subsequent infusions: May require separate site-of-care review
  • Re-initiation: After 6+ months off therapy, treated as new course
Provider Tip: Verify network participation before scheduling. Out-of-network infusion centers may result in higher patient costs.

Evidence to Support Medical Necessity

Key Guidelines to Reference

  1. 2022 American Thyroid Association/European Thyroid Association Guidelines
  2. FDA prescribing information for teprotumumab
  3. Ophthalmology society recommendations for TED management

Peer-Reviewed Evidence

When writing appeals, cite:

  • OPTIC and OPTIC-X trials (pivotal FDA approval studies)
  • Real-world effectiveness data from major medical centers
  • Safety monitoring guidelines for infusion reactions and hearing

How to Cite Effectively

  • Include specific guideline recommendations
  • Reference FDA label sections
  • Note any off-label uses with supporting literature
  • Document why alternatives are inadequate

Sample "Meets Criteria" Documentation

Medical Necessity Letter Template

"This 45-year-old patient has active thyroid eye disease (ICD-10: H05.20) with a Clinical Activity Score of 5/7, including spontaneous retrobulbar pain, pain on eye movement, and significant eyelid swelling. Proptosis measures 24mm OD and 23mm OS by Hertel exophthalmometry, representing moderate-to-severe disease.

The patient has achieved euthyroid status (TSH 2.1 mIU/L, Free T4 1.3 ng/dL) and previously failed a 3-month course of oral prednisone due to inadequate response and steroid-induced hyperglycemia. Current symptoms significantly impact quality of life with diplopia affecting driving and work performance.

Tepezza (teprotumumab) is FDA-approved for thyroid eye disease and represents the only targeted therapy for this condition. The requested 8-infusion course aligns with FDA labeling and clinical trial protocols. The patient meets all coverage criteria and will be monitored closely for infusion reactions and glucose changes."

Edge Cases and Special Situations

Pregnancy and Reproductive Health

  • Contraindicated in pregnancy: Requires negative pregnancy test
  • Contraception required: During treatment and 6 months after
  • Documentation needed: Contraceptive plan in medical record

Diabetes Considerations

  • Increased monitoring: Blood glucose checks during infusions
  • Risk documentation: Note diabetes as relative contraindication overcome by benefit
  • Management plan: Endocrinology consultation recommended

Pediatric Patients

  • Age restriction: FDA approval limited to adults (≥18 years)
  • Off-label use: Requires extensive justification and literature support

Retreatment Scenarios

  • Disease progression: Document new/worsening symptoms with CAS scores
  • Time interval: Note time since last course completion
  • Alternative failures: Show inadequate response to other interventions

Appeals Process in Florida

Internal Appeal Timeline

  1. File within: 180 days of denial notice
  2. Decision timeframe: 30 days for prospective services, 60 days for retrospective
  3. Submit to: Prime Therapeutics (delegate) via Florida Blue portal

External Review Process

If internal appeal fails:

  • File within: 60 days of final denial
  • Decision timeframe: Up to 60 days (4 business days if urgent)
  • Contact: MAXIMUS Federal Services at (800) 866-6205
  • Cost: No charge to patient

Required Documentation for Appeals

  • Original denial letter
  • Complete medical records
  • Updated CAS scores and measurements
  • Letter of medical necessity
  • Supporting literature/guidelines
Expedited Appeals: Available for urgent situations where delay could jeopardize health. Request simultaneously with standard appeal.

Florida Consumer Assistance: Call the Insurance Consumer Helpline at (877) 693-5236 for help navigating appeals.

Quick Reference: Coverage Criteria

Criteria Requirement Documentation Source
Prior Authorization Required Submit via Availity.com or 1-877-719-2583 Florida Blue PA
Diagnosis Active TED ICD-10: H05.20-H05.22 Plan policy
Disease Activity CAS ≥4 Complete assessment form CAS Documentation
Thyroid Status Euthyroid/mild abnormal Labs within 90 days Prime Therapeutics
Prescriber Ophthalmologist/Endocrinologist Provider credentials Plan policy
Course Limit 8 infusions 6-month authorization Plan policy
Billing Code J3241 (10 mg = 1 unit) Correct unit calculation Billing Guide

FAQ

How long does Florida Blue PA take? Typically 7-14 business days. Expedited reviews available for urgent cases within 72 hours.

What if Tepezza is non-formulary on my plan? Request a formulary exception with medical necessity documentation. All Florida Blue plans must have an exception process.

Can I appeal if my CAS score is only 3? Yes. Document functional impairment, progression, or cite newer guidelines that support treatment at lower CAS scores.

Does step therapy apply if I failed steroids years ago? Document the prior failure clearly. Recent trials may be required depending on time elapsed and clinical changes.

What if my ophthalmologist isn't in Florida Blue's network? Request a network adequacy exception if no in-network TED specialists are available within reasonable distance.

How much will Tepezza cost me? Varies by plan. Commercial patients may qualify for Tepezza copay assistance. Full course typically costs $350,000-500,000 without coverage.

Can I get a second opinion for my appeal? Yes. External review provides independent medical expert evaluation at no cost to you.

What happens if I miss an infusion due to insurance delays? Coordinate with your provider to maintain the every-3-week schedule when possible. Document any delays caused by PA issues for appeals.

How Counterforce Health Can Help

Navigating Tepezza coverage with Florida Blue involves complex medical necessity criteria, detailed documentation requirements, and tight appeal deadlines. Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing your specific denial reason and crafting point-by-point rebuttals aligned to your plan's own rules. Our platform pulls the right clinical evidence—from FDA labeling to peer-reviewed TED studies—and weaves them into appeals that meet Florida's procedural requirements while tracking critical deadlines.

For patients facing Tepezza denials, we help identify whether the issue is missing PA criteria, inadequate CAS documentation, or billing errors, then provide the clinical facts and operational details payers expect. This targeted approach reduces the back-and-forth that often delays treatment for this sight-threatening condition.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by specific plan and may change. Always verify current requirements with Florida Blue directly and consult your healthcare provider for medical decisions. For personalized assistance with insurance appeals, consider consulting with coverage advocates or legal professionals specializing in health insurance matters.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.